Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculo-neuropathy

Neurology

Volumn 37, Issue 1, 1987, Pages 147-149

  Kolkin, Seth ^a   Nahman, N S ^a   Mendell, Jerry R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PREDNISONE;

ADVERSE DRUG REACTION; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CASE REPORT; CENTRAL NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DEMYELINATION; DRUG THERAPY; GUILLAIN BARRE SYNDROME; HUMAN; INTOXICATION; KIDNEY; KIDNEY FAILURE; NEPHROTOXICITY; NERVOUS SYSTEM; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; THERAPY;

ADULT; CASE REPORT; CREATININE; CYCLOSPORINS; DEMYELINATING DISEASES; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE, CHRONIC; POLYRADICULONEUROPATHY; RENAL DIALYSIS;

EID: 0023080574     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.37.1.147     Document Type: Article

References (16)

1. Cohen DJ, Loertscher R, Rubin MR, Tihey NL, Carpenter CB, Strom TB. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 1984;101:667–82.
2. Von Graffenried B, Harrison WB. Renal function in patients with autoimmune diseases treated with cyclosporine. Transplant Proc 1985;17(suppl 1):215–31.
3. Johnson KP, Belendiuk G. Use of cyclosporine in neurological autoimmune disease? Arch Neurol 1985;42:1043–4.
4. Zabel P, Leimenstoll G, Gross WL. Cyclosporin for acute dermatomyositis. Lancet 1984;1:343.
5. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621–37.
6. Palestine AG, Austin HA, Nussenblatt RB. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis. Transplant Proc 1985;17(suppl 1):209–14.
7. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1981;311:699–706.
8. Strom TB, Loertscher R. Cyclosporine-induced nephrotoxicity, N Engl J Med 1984;311:728–9.
9. Sommer BG, Innes JT, Whitehurst RM, Sharma HM, Ferguson RM. Cyclosporine-associated renal arteriopathy resulting in loss of allograft function. Am J Surg 1985;149:756–64.
10. Brooke MH, Fenichel GM, Griggs RC, et al, and the CIDD Group. Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 1983:6, 91–103.
11. Keown PA, Stiller CR, Sinclair NR, et al. The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay. Transplant Proc 1983;15(suppl 1):2438–41.
12. Keown PA, Stiller CR, Laupacis AL, et al. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc 1982;14:659–61.
13. White DJG, McNaughton D, Caine RY. Is the monitoring of cyclosporin-A serum levels of clinical value? Transplant Proc 1983;15:454–6.
14. Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 1981;305:1392–5.
15. Leithner C, Sinzinger H, Pohanka E, Schwarz M, Kretschmer G, Syre G. Occurrence of hemolytic uremic syndrome under cyclosporine treatment: accident or possible side effect mediated by a lack of prostacyclin-stimulating plasma factor? Transplant Proc 1983;15(suppl 1):2787–9.
16. Ryffel B, Siegl H, Mueller AM, Hauser R, Mihatsch MJ. Nephrotoxicity of cyclosporine in, spontaneously hypertensive rats. Transplant Proc 1985;17:1430–1.